Empery Asset Management’s BioCardia, Inc. Warrant BCDAW Stock Holding History

Empery Asset Management’s Portfolio BCDAW Stock Details BCDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$15K	Hold	18,459	–	–	0.09%	66
2022 Q2	$6K	Hold	18,459	–	–	0.03%	67
2022 Q1	$8K	Hold	18,459	–	–	0.04%	73
2021 Q4	$20K	Buy	+18,459	New	+$23.8K	0.04%	64

Other funds holding BCDAW

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Empery Asset Management's BCDAW Position: Q3 2022 in Review

Empery Asset Management held its BioCardia, Inc. Warrant (BCDAW) position steady in Q3 2022 at 18,459 shares worth $15K. The position accounts for 0.09% of the portfolio, ranked #66.

Empery Asset Management first reported a position in BCDAW in Q4 2021 and has held it in 4 quarters since. The position peaked at $20K in Q4 2021. 5 funds tracked by Wall St. Rank hold BCDAW as of Q3 2022.

Empery Asset Management held 18,459 shares of BioCardia, Inc. Warrant worth $15K as of Q3 2022.
Empery Asset Management left its BioCardia, Inc. Warrant share count unchanged in Q3 2022.
BioCardia, Inc. Warrant made up 0.09% of Empery Asset Management's portfolio in Q3 2022, its #66 holding.
Empery Asset Management first reported a position in BioCardia, Inc. Warrant in Q4 2021 and has held it in 4 quarters since.
Empery Asset Management's BioCardia, Inc. Warrant position peaked at $20K in Q4 2021.
5 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.